Skip to search formSkip to main contentSkip to account menu

CDB 2914

Known as: CDB-2914 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
OBJECTIVE: To evaluate whether 3-month administration of CDB-2914, a selective progesterone receptor modulator, reduces leiomyoma… 
Review
2008
Review
2008
BACKGROUND Emergency contraception is using a drug or copper intrauterine device (Cu-IUD) to prevent pregnancy shortly after… 
Highly Cited
2008
Highly Cited
2008
Effects of progesterone receptor modulator CDB-2914 on the expression of the extracellular matrix (ECM) components were examined… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND This study was conducted to evaluate the effects of graded concentrations (10(-8), 10(-7) and 10(-6) M) of… 
Highly Cited
2006
Highly Cited
2006
Background: All current major medications in treating endometriosis are effective in treating pain, most likely through… 
Highly Cited
2005
Highly Cited
2005
The present study was conducted to evaluate the effects of the progesterone receptor modulator CDB-2914 on proliferative activity… 
2003
2003
BACKGROUND Progesterone receptor modulators have potential therapeutic use in progesterone-dependent conditions such as… 
Highly Cited
2000
Highly Cited
2000
Previous studies in women have shown that the antiprogestin mifepristone delays or inhibits folliculogenesis. The purpose of this… 
Highly Cited
2000
Highly Cited
2000
Our goal was to determine the endocrine and post-coital anti-fertility activity of CDB-2914. Concurrent administration of…